Hedge Funds Get Boost From Healthcare In 2014VW Staff
The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotechnology Index has returned 18.35% so far this year, which beats the 3.74% return churned out by hedge funds across all strategies.
The shakedown of healthcare stocks provided hedge funds with a favorable entry point. Pharma . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.